• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Efficacy of liver transplantation for acute hepatic failure: a single-center experience

    2011-07-05 12:59:32XianJieShiHongBinXuWenBinJiYuRongLiangWeiDongDuanLeiHeMingJunWangandZhiMingZhao

    Xian-Jie Shi, Hong-Bin Xu, Wen-Bin Ji, Yu-Rong Liang, Wei-Dong Duan, Lei He, Ming-Jun Wang and Zhi-Ming Zhao

    Beijing, China

    Efficacy of liver transplantation for acute hepatic failure: a single-center experience

    Xian-Jie Shi, Hong-Bin Xu, Wen-Bin Ji, Yu-Rong Liang, Wei-Dong Duan, Lei He, Ming-Jun Wang and Zhi-Ming Zhao

    Beijing, China

    BACKGROUND:Acute hepatic failure (AHF) is a devastating clinical syndrome with a high mortality rate. The outcome of AHF varies with etiology, but liver transplantation (LT) can significantly improve the prognosis and survival rate of such patients. This study aimed to detect the role of LT and artificial liver support systems (ALSS) for AHF patients and to analyze the etiology and outcome of patients with this disease.

    METHODS:A retrospective analysis was made of 48 consecutive patients with AHF who fulfilled the Kings College Criteria for LT at our center. We analyzed and compared the etiology, outcome, prognosis, and survival rates of patients between the transplantation (LT) group and the non-transplantation (N-LT) group.

    RESULTS:AHF was due to viral hepatitis in 25 patients (52.1%; hepatitis B virus in 22), drug or toxic reactions in 14 (29.2%; acetaminophen in 6), Wilson disease in 4 (8.3%), unknown reasons in 3 (6.3%), and miscellaneous conditions in 2 (4.2%). In the LT group, 36 patients (7 underwent living donor LT, and 29 cadaveric LT) had an average model for endstage liver disease score (MELD) of 35.7. Twenty-eight patients survived with good graft function after a follow-up of 27.3± 4.5 months. During the waiting time, 6 patients were treated with ALSS and 2 of them died during hospitalization. The 30-day, 12-month, and 18-month survival rates were 77.8%, 72.2%, and 66.7%, respectively. In the N-LT group, 12 patients had an average MELD score of 34.5. Four patients were treated with ALSS and all died during hospitalization. The 90-day and 1-year survival rates were only 16.7% and 8.3%, respectively.

    CONCLUSIONS:Hepatitis is the most prominent cause of AHF at our center. Most patients with AHF, who fulfill the Kings College Criteria for LT, did not survive longer without LT. ALSS did not improve the prognosis of AHF patients, but may extend the waiting time for a donor. Currently, LT is still the most effective way to improve the prognosis of AHF patients.

    (Hepatobiliary Pancreat Dis Int 2011; 10: 369-373)

    acute hepatic failure; liver transplantation; arti ficial liver support; prognosis; survival rate; etiology

    Introduction

    Acute hepatic failure (AHF) is a severe condition, which often affects young persons and is associated with a high mortality rate. Moreover, the outcome of AHF varies etiologically and geographically; however, the prognosis of this disorder improves dramatically after liver transplantation (LT). The most widely accepted definition of AHF includes evidence of coagulation abnormality, which is typically determined by the prothrombin time (prothrombin index <40% or international normalized ratio ≥1.5), and any degree of mental alteration (encephalopathy) in patients without pre-existing cirrhosis or with an illness of <26 weeks duration. Patients with Wilson disease, verticallyacquired HBV, or autoimmune hepatitis may be included in spite of the possibility of cirrhosis, if their disease is recognized for <26 weeks.[1]

    This catastrophic illness can progress rapidly resulting in the placement of the patient in a coma and/or death from cerebral edema or multi-organ dysfunction. The reported survival rate of patients with AHF is less than 15% before LT, while the overall short-term survival rate after LT is more than 65%.[2]The present study was undertaken to assess the roleof LT and artificial liver support system (ALSS) in the treatment of AHF patients, and to analyze the etiology of the disease and the outcome of treatment at our center.

    Methods

    We retrospectively reviewed 48 consecutive patients with AHF treated at our center from March 2005 to June 2009, who fulfilled the Kings College Criteria for LT. AHF was diagnosed by clinical, analytical, and histological results. Etiology of the disease, age and sex of the patients, MELD score, perioperative complications, artificial liver support, continuous renal replacement therapy (CRRT), waiting time, causes of death, and survival time were recorded and analyzed. Informed consent was obtained from the patients or their relatives before the study. The study was approved by the Ethics Committee of the General Hospital of PLA.

    General information

    Forty-eight patients (20 males and 28 females) were divided into two groups: a transplantation (LT) group of 36 patients, who had undergone LT, and a nontransplantation (N-LT) group of 12, who had not. The average age of the patients was 34.1±4.9 years, and the MELD score was 35.2±7.9. In the LT group, 6 patients were given ALSS, 6 were given CRRT before surgery, and 6 were given CRRT after surgery. In the N-LT group, 4 patients were given ALSS and 2 were given CRRT (Table 1).

    Etiology

    AHF was due to viral hepatitis in 25 patients (52.1%; hepatitis B virus in 22 patients), drug or toxic reactions in 14 (29.2%; acetaminophen in 6), Wilson disease in 4 (8.3%), unknown reasons in 3 (6.3%), and miscellaneous conditions in 2 (4.2%) (Fig.1).

    Table 1. General information of patients in two groups before operation

    Treatment and follow-up

    Seven patients underwent living donor LT, and 29 received a cadaveric whole liver. Thirty-four pairs of donors and recipients had the same ABO blood type, while the other two pairs were type-B recipients of type-O donors. Other operative data are shown in Table 2. Immunosuppression was based on a regimen of FK506, MMF, and prednisone in all patients. Other than LT, the medical treatments used in both groups were the same, including liver protection, anti-infection, nutritional support and anti-hepatic encephalopathy. The follow-up interval was from the date of diagnosis to death or December 2010.

    Statistical analysis

    Data were analyzed on a CHISS system (Windows version 3.0.0.21). Baseline data were presented as mean± SD. Actuarial survival rates were calculated by the Kaplan-Meier method.

    Results

    During the period of hospitalization, 19 patients died of brain edema and refractory intracranial hypertension, multi-organ failure (MOF), sepsis, renal failure, coagulation disorders (intracranial hemorrhage, upper digestive tract hemorrhage), acute respiratory distress syndrome, and primary graft non-function.

    Fig. 1. Causes of 48 patients with AHF. LT: transplantation group; N-LT: non-transplantation group; AIH: autoimmune hepatitis; AHF: acute hepatic failure.

    Table 2. Operative information

    Fig. 2. The survival rate was significantly greater in the LT group than in the N-LT group (P<0.001). LT: transplantation group; N-LT: non-transplantation group.

    In the LT group, 8 patients died during their hospitalization, while 28 patients survived and showed good graft function during the median follow-up time of 27.3±4.5 months. The average waiting time for LT was 78±16 hours. During the waiting period, 6 patients were treated with ALSS and 2 of them died after LT. After surgery, 6 patients were given CRRT, but only 2 of these patients survived. Five patients who exhibited vascular or biliary complications recovered after interventional or surgical therapy. The 30-day, 12-month, and 18-month survival rates were 77.8%, 72.2% and 66.7%, respectively. In the N-LT group, only one patient survived longer. Four patients were given ALSS, but all died during the period of hospitalization. The 90-day and 1-year survival rates were only 16.7% and 8.3%, respectively. In all 29 long-term surviving patients, 19 experienced a good quality of life and resumed their normal activities. The survival rate was significantly greater in the LT group than in the N-LT group (χ2=14.846, P<0.001, Fig. 2). In patients who received ALSS, the level of serum bilirubin was significantly reduced, in addition to a marked regression of pruritus. Moreover, hepatic encephalopathy was also improved and no severe events occurred in patients receiving ALSS.

    Discussion

    AHF is a condition, which can progress rapidly with daily changes in consciousness and coagulation. Because AHF may result in such lethal complications as MOF, hepatic encephalopathy, and coagulation disorders, immediate etiological identification and intensive care are crucial. LT may remarkably improve the prognosis of patients with AHF;[3]however, not all patients with AHF should undergo transplantation. Because of the shortage of organ donors and the growing demand, patients should be evaluated carefully for LT.

    The most frequently accepted criteria for LT in AHF patients are the Kings College Hospital criteria[4]and the Clichy criteria,[5]even though these criteria were formulated a decade ago. Compared to the Kings College Hospital criteria proposed by O'Grady, validation studies of the Clichy criteria are scarce, and its derivation was from a cohort of patients with AHF resulting from a single condition.[6]Hence, in our study, we used the Kings College Hospital criteria, which differentiate patients with acetaminophen-induced hepatotoxicity from those with other causes (nonacetaminophen-induced hepatotoxicity) of AHF,[6,7]to evaluate whether LT is needed or not.

    Despite the improvement of therapeutic modalities in intensive care medicine, AHF is still an intractable condition with a high mortality rate.[8]In our patients, the most common causes of death were MOF, renal failure, sepsis, brain edema, and refractory intracranial hypertension. Although we took many measures such as CRRT, ALSS, and medical treatments to prevent or remedy these complications, many patients died.

    In our experience, we found several important factors to consider when caring for patients with AHF. First, the maintenance of hemodynamic stability is a key for preventing renal failure. Although renal failure alone rarely leads to death, once it occurs the patient's prognosis is poor.[9]After surgery, 6 patients in our study required CRRT, but only 2 survived. Second, the pathogenesis of brain edema and refractory intracranial hypertension is poorly understood, but its incidence and severity are closely associated with hepatic encephalopathy. In patients with hepatic encephalopathy at stagesito II, brain edema is rare; yet patients at stage III exhibit a risk of 25%-35% for developing brain edema and the risk to patients at stage IV increases to 65%-75% or more.[10,11]These increased risks highlight the importance of monitoring intracranial pressure in patients with grade III/IV encephalopathy. Therefore, moderate hypothermia might be a promising treatment for patients with refractory intracranial hypertension,[12]other measures, such as head elevation, plasma colloid elevation, and/or application of mannitol may also be effective treatments.[13]Third, it is of utmost importance to immediately address any observed infections by shortening the time for the patient on mechanical ventilation, removing or reducing the factors which aggravate or induce infections, and adjusting doses of anti-infection agents.

    AHF is a fatal condition that remains poorly understood, but defining the etiology is of great importance in predicting the patient's prognosis.[14]Theetiology of AHF is significantly different in geography and times. In east Asia and developing countries, AHF is mainly due to viral infections, such as hepatitis B, A, and E. In the United States and Western Europe, the incidence of virus-induced disease has declined substantially in recent years, with most cases now arising from drug-induced liver injury.[15]In Bangladesh, acute HEV infections are the leading cause of AHF.[16]In our study, more than half of the patients with AHF were attributed to hepatitis (19 patients in the LT group and 6 in the N-LT group) infections, especially hepatitis B (45.8%), and may be one of the reasons for the higher mortality in our N-LT group.

    The lack of donor livers and other transplant-related problems leads to the death of many patients during the waiting period. In the United States, over 30% of patients listed for emergency LT will die while waiting for a graft.[17]Besides standard medical therapy, ALSS or hepatocyte transplantation is currently used for treating AHF.[18-20]In this study, we used the molecular adsorbent recirculation system, ALSS, which is an extracorporeal artificial liver support system that contains no biologic components. ALSS can remove endotoxins, bilirubin, and other toxic substances from the body, add a variety of plasma coagulation factors, treat hyperbilirubinemia, and improve blood coagulation and consciousness of patients with hepatic encephalopathy. In our LT group, 6 patients were treated with ALSS during the waiting time and 2 of them died during the period of hospitalization. In the N-LT group, 4 patients were treated with ALSS and all died during hospitalization. Apparently, ALSS may extend the waiting time for a donor and serves as a bridge for patients with AHF and needing a LT, but it does not improve the mortality and prognosis of AHF patients.[21]Of course, the use of ALSS as a therapeutic option is still under investigation and lacks proven longterm successful results, thus making LT the final and most effective therapy.

    At times, AHF patients have to receive an ABO-incompatible donor liver to save their lives.[22]It is reported that ABO-incompatibility has no significant impact on patient survival. However, graft survival is significantly impaired by hyperacute rejection (20%), vascular thrombosis, and biliary injury (56%).[23]In our study, there were two type B recipients from type O donors, and both exhibited long-term survival. This result showed that even ABO-incompatible liver grafts can be used in the emergency, life-saving treatment of patients with AHF.

    In summary, unlike in developed countries, viral infections, especially hepatitis B, were the most prominent causes of AHF in this study. In the N-LT group, all but one patient died. ALSS did not improve the prognosis of AHF patients, but did extend the waiting time for a donor. The use of ABO-incompatible liver grafts is a possible life-saving method for the emergency treatment of patients with AHF. Most patients with AHF, who fulfilled the Kings College Criteria for LT, would not survive longer if LT is not performed. In spite of great improvement in medication, LT is still currently the most effective way for improving the prognosis of AHF patients. Because of the limitations of LT, final decisions for LT should depend upon rapid diagnosis and accurate prognostic evaluation. Although new therapies for AHF are still being investigated, alternative treatment modalities also require further study.

    Funding:None.

    Ethical approval:The study was approved by the Ethics Committee of the General Hospital of PLA, China.

    Contributors:SXJ proposed and designed the study. SXJ and LYR wrote the first draft. XHB and JWB analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. SXJ is the guarantor.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.

    2 Ostapowicz G, Fontana RJ, Schi?dt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.

    3 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008;47:1401-1415.

    4 O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.

    5 Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995;222:109-119.

    6 Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004;40:192-197.

    7 Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000;6:170-173.

    8 Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, N?ldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001;12:S75-82.

    9 Murphy EJ, Davern TJ, Shakil AO, Shick L, Masharani U, Chow H, et al. Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group. Dig Dis Sci 2000;45:549-553.

    10 Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003;23:259-269.

    11 Cordoba J, Blei AT. Cerebral edema and intracranial pressure monitoring. Liver Transpl Surg 1995;1:187-194.

    12 Detry O, De Roover A, Honore P, Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol 2006;12:7405-7412.

    13 Blei AT. Monitoring cerebral blood flow: a useful clinical tool in acute liver failure? Liver Transpl 2005;11:1320-1322.

    14 MacQuillan G. Predicting outcome in acute liver failure: are we there yet? Liver Transpl 2007;13:1209-1211.

    15 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010;376:190-201.

    16 Mahtab MA, Rahman S, Khan M, Mamun AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobiliary Pancreat Dis Int 2008;7:161-164.

    17 Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003;23:217-226.

    18 Wu CX, Zou Q, Zhu ZY, Gao YT, Wang YJ. Intrahepatic transplantation of hepatic oval cells for fulminant hepatic failure in rats. World J Gastroenterol 2009;15:1506-1511.

    19 Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, et al. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009;15: 3377-3388.

    20 Pareja E, Cortes M, Bonora A, Fuset P, Orbis F, Lopez R, et al. New alternatives to the treatment of acute liver failure. Transplant Proc 2010;42:2959-2961.

    21 Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003;289:217-222.

    22 Saliba F, Ichai P, Azoulay D, Habbouchi H, Antonini T, Sebagh M, et al. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns. Ther Apher Dial 2010;14:116-123.

    23 Farges O, Kalil AN, Samuel D, Saliba F, Arulnaden JL, Debat P, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59:1124-1133.

    Received September 30, 2010

    Accepted after revision April 18, 2011

    Author Affiliations: Department of Hepatobiliary Surgery (Shi XJ, Xu HB, Ji WB, Liang YR, Duan WD, Heland Zhao ZM), and Department of Anesthesiology (Wang MJ), General Hospital of PLA, Beijing 100853, China

    Xian-Jie Shi, MD, Department of Hepatobiliary Surgery, General Hospital of PLA, Beijing 100853, China (Tel: 86-10-68241383; Email: shixianjie301@yahoo.com.cn)

    ? 2011, Hepatobiliary Pancreat Dis Int. All rights reserved.

    亚洲精品自拍成人| 久久久久久久久免费视频了| 日日爽夜夜爽网站| 国产精品国产高清国产av | 亚洲精品在线美女| 每晚都被弄得嗷嗷叫到高潮| 久久亚洲精品不卡| 午夜福利在线观看吧| av网站在线播放免费| 久久久精品94久久精品| 9191精品国产免费久久| 国产男靠女视频免费网站| 欧美激情极品国产一区二区三区| 女警被强在线播放| e午夜精品久久久久久久| 免费一级毛片在线播放高清视频 | 亚洲伊人久久精品综合| 久久影院123| 丰满少妇做爰视频| 色在线成人网| 亚洲av第一区精品v没综合| 操美女的视频在线观看| 超碰成人久久| 精品国产一区二区三区四区第35| 亚洲精品中文字幕一二三四区 | 国产欧美日韩一区二区三| 69av精品久久久久久 | 久久av网站| 亚洲精品自拍成人| 天堂8中文在线网| 国产日韩欧美视频二区| 99精品欧美一区二区三区四区| 日韩大码丰满熟妇| 怎么达到女性高潮| 91字幕亚洲| 久久久久精品人妻al黑| 99热国产这里只有精品6| 一级毛片女人18水好多| 999精品在线视频| 欧美黄色片欧美黄色片| 1024视频免费在线观看| 9色porny在线观看| 亚洲精品中文字幕在线视频| 国产不卡av网站在线观看| 久久久久久久精品吃奶| 久久久精品94久久精品| 国产无遮挡羞羞视频在线观看| 欧美激情 高清一区二区三区| 又大又爽又粗| 脱女人内裤的视频| 久久久久久久大尺度免费视频| 高清视频免费观看一区二区| 人人妻人人澡人人看| 少妇猛男粗大的猛烈进出视频| 12—13女人毛片做爰片一| www.999成人在线观看| 国产精品偷伦视频观看了| 最新美女视频免费是黄的| 一级黄色大片毛片| 99国产精品免费福利视频| 欧美成狂野欧美在线观看| 两个人看的免费小视频| 欧美日韩亚洲高清精品| 成在线人永久免费视频| 国产97色在线日韩免费| 777久久人妻少妇嫩草av网站| 久久亚洲精品不卡| 亚洲熟女精品中文字幕| 久久99热这里只频精品6学生| 美女视频免费永久观看网站| 午夜福利在线免费观看网站| 国产区一区二久久| 免费在线观看视频国产中文字幕亚洲| 久久久久久免费高清国产稀缺| 国产真人三级小视频在线观看| 1024香蕉在线观看| 日韩熟女老妇一区二区性免费视频| 亚洲av电影在线进入| 啪啪无遮挡十八禁网站| 欧美乱妇无乱码| 成人三级做爰电影| 捣出白浆h1v1| 午夜福利,免费看| 99国产综合亚洲精品| 免费看十八禁软件| 大码成人一级视频| 看免费av毛片| 高清欧美精品videossex| 欧美亚洲日本最大视频资源| 巨乳人妻的诱惑在线观看| 亚洲熟妇熟女久久| 欧美精品一区二区大全| 黄色片一级片一级黄色片| 高清在线国产一区| 丰满少妇做爰视频| 美女视频免费永久观看网站| 亚洲精品久久成人aⅴ小说| 国产精品一区二区在线观看99| 亚洲人成电影观看| 少妇的丰满在线观看| 啦啦啦中文免费视频观看日本| 曰老女人黄片| 国产精品久久久av美女十八| 俄罗斯特黄特色一大片| 一进一出抽搐动态| 丰满迷人的少妇在线观看| 99国产精品一区二区三区| 91字幕亚洲| 亚洲男人天堂网一区| 亚洲av日韩在线播放| 国产国语露脸激情在线看| 搡老乐熟女国产| 午夜福利影视在线免费观看| 日本五十路高清| 日韩视频在线欧美| 亚洲精品国产精品久久久不卡| 视频在线观看一区二区三区| 狂野欧美激情性xxxx| 中文字幕av电影在线播放| 侵犯人妻中文字幕一二三四区| 亚洲成人免费av在线播放| 日本黄色日本黄色录像| 久久精品成人免费网站| 日韩中文字幕视频在线看片| 午夜福利视频精品| 热re99久久精品国产66热6| 午夜福利乱码中文字幕| 少妇裸体淫交视频免费看高清 | 国产精品欧美亚洲77777| 久久精品亚洲精品国产色婷小说| 在线亚洲精品国产二区图片欧美| 国产精品香港三级国产av潘金莲| 久久久国产精品麻豆| 久久久久久久久久久久大奶| 麻豆国产av国片精品| 中文字幕色久视频| 久久国产亚洲av麻豆专区| 亚洲五月色婷婷综合| av天堂在线播放| 人妻 亚洲 视频| 亚洲精品国产精品久久久不卡| 亚洲人成电影观看| 人妻久久中文字幕网| 丰满少妇做爰视频| 久久久久久人人人人人| 人人妻人人爽人人添夜夜欢视频| 久久亚洲真实| 一区二区三区国产精品乱码| av视频免费观看在线观看| 亚洲熟女精品中文字幕| 免费日韩欧美在线观看| 91精品三级在线观看| 菩萨蛮人人尽说江南好唐韦庄| 女性被躁到高潮视频| 亚洲成人国产一区在线观看| 成人国产av品久久久| 日本a在线网址| 搡老乐熟女国产| 久久久久久久国产电影| 日本a在线网址| 亚洲欧洲精品一区二区精品久久久| 午夜视频精品福利| 国产欧美日韩精品亚洲av| 一进一出好大好爽视频| 老司机靠b影院| 日韩欧美一区二区三区在线观看 | 我要看黄色一级片免费的| 婷婷成人精品国产| 国产欧美日韩一区二区三| 国产成人精品久久二区二区91| 极品人妻少妇av视频| 啦啦啦中文免费视频观看日本| 久热爱精品视频在线9| 国产精品久久久av美女十八| 国产免费现黄频在线看| 亚洲精华国产精华精| 女警被强在线播放| 国产av国产精品国产| 免费在线观看影片大全网站| 久久中文字幕人妻熟女| 中文字幕最新亚洲高清| 天天躁狠狠躁夜夜躁狠狠躁| 欧美人与性动交α欧美精品济南到| av电影中文网址| 日韩欧美一区二区三区在线观看 | 2018国产大陆天天弄谢| 999精品在线视频| 久久人妻熟女aⅴ| 两个人看的免费小视频| 国产真人三级小视频在线观看| 麻豆av在线久日| 久久ye,这里只有精品| 黄色片一级片一级黄色片| 国产精品成人在线| 国产精品欧美亚洲77777| 99国产精品一区二区三区| tube8黄色片| 免费高清在线观看日韩| 久久性视频一级片| 91大片在线观看| 一边摸一边抽搐一进一出视频| 国产男靠女视频免费网站| 五月开心婷婷网| 两性夫妻黄色片| 2018国产大陆天天弄谢| 国产精品国产高清国产av | 日本五十路高清| 国产成人精品在线电影| 久久这里只有精品19| 亚洲欧美一区二区三区久久| av欧美777| 女警被强在线播放| 精品国产亚洲在线| 电影成人av| 丝袜美足系列| 十八禁网站免费在线| 亚洲国产欧美在线一区| 日韩欧美国产一区二区入口| tocl精华| 国产精品98久久久久久宅男小说| 亚洲第一青青草原| 欧美日韩视频精品一区| 真人做人爱边吃奶动态| 嫩草影视91久久| 男女之事视频高清在线观看| av网站在线播放免费| 欧美成人午夜精品| 亚洲,欧美精品.| 日本一区二区免费在线视频| 丝袜美足系列| 日韩精品免费视频一区二区三区| 中文欧美无线码| 啦啦啦视频在线资源免费观看| 99久久人妻综合| 国产一区二区三区在线臀色熟女 | 91国产中文字幕| 黄色毛片三级朝国网站| 亚洲第一青青草原| 色尼玛亚洲综合影院| 精品一区二区三区视频在线观看免费 | 男人操女人黄网站| 黑人猛操日本美女一级片| 国产精品影院久久| 一区在线观看完整版| 亚洲一区中文字幕在线| 99精国产麻豆久久婷婷| 真人做人爱边吃奶动态| 天堂动漫精品| 亚洲免费av在线视频| 色老头精品视频在线观看| 考比视频在线观看| 国产精品偷伦视频观看了| 天堂8中文在线网| 成人国产一区最新在线观看| 91成年电影在线观看| 中文字幕人妻熟女乱码| 精品少妇久久久久久888优播| 欧美成人午夜精品| a级片在线免费高清观看视频| 欧美在线一区亚洲| 久久人妻av系列| 日本五十路高清| 夜夜爽天天搞| 精品国内亚洲2022精品成人 | 深夜精品福利| 男女高潮啪啪啪动态图| avwww免费| 操美女的视频在线观看| 老熟女久久久| 日本一区二区免费在线视频| 悠悠久久av| 国产黄色免费在线视频| 岛国在线观看网站| 久久人妻熟女aⅴ| 男男h啪啪无遮挡| 欧美激情 高清一区二区三区| 人妻久久中文字幕网| 乱人伦中国视频| 亚洲色图 男人天堂 中文字幕| 女性被躁到高潮视频| 精品久久久久久久毛片微露脸| 亚洲情色 制服丝袜| 国产又爽黄色视频| 极品人妻少妇av视频| 蜜桃国产av成人99| 国产精品偷伦视频观看了| 9热在线视频观看99| 91av网站免费观看| 精品卡一卡二卡四卡免费| 十八禁网站免费在线| 在线播放国产精品三级| 国产日韩欧美在线精品| 国产单亲对白刺激| 午夜福利视频在线观看免费| 亚洲免费av在线视频| 18禁观看日本| 美女主播在线视频| 少妇粗大呻吟视频| 18在线观看网站| 成年人午夜在线观看视频| 大陆偷拍与自拍| 啦啦啦中文免费视频观看日本| 国产91精品成人一区二区三区 | 老汉色av国产亚洲站长工具| 久久人人爽av亚洲精品天堂| 亚洲成人国产一区在线观看| 久久午夜综合久久蜜桃| 亚洲视频免费观看视频| 亚洲欧洲精品一区二区精品久久久| 亚洲国产看品久久| 成人三级做爰电影| 国产精品香港三级国产av潘金莲| 高清av免费在线| 国产野战对白在线观看| 日本wwww免费看| 纯流量卡能插随身wifi吗| 香蕉国产在线看| 精品少妇一区二区三区视频日本电影| 一级片免费观看大全| 亚洲自偷自拍图片 自拍| 国产男女超爽视频在线观看| 王馨瑶露胸无遮挡在线观看| 精品久久久久久久毛片微露脸| 日日爽夜夜爽网站| 欧美日韩中文字幕国产精品一区二区三区 | 在线观看免费视频日本深夜| 1024视频免费在线观看| 在线观看免费视频日本深夜| 嫁个100分男人电影在线观看| 亚洲专区国产一区二区| 国产黄色免费在线视频| 侵犯人妻中文字幕一二三四区| 久久久久久久久久久久大奶| 我要看黄色一级片免费的| 亚洲第一青青草原| 欧美亚洲 丝袜 人妻 在线| 亚洲人成77777在线视频| 精品久久久久久电影网| av电影中文网址| 欧美变态另类bdsm刘玥| 后天国语完整版免费观看| 91精品国产国语对白视频| 亚洲欧美色中文字幕在线| 亚洲精品自拍成人| 久久国产亚洲av麻豆专区| 亚洲国产毛片av蜜桃av| 超色免费av| 久久99热这里只频精品6学生| 无遮挡黄片免费观看| 一边摸一边抽搐一进一小说 | 一级毛片女人18水好多| 亚洲国产毛片av蜜桃av| 国产黄频视频在线观看| 亚洲欧美日韩高清在线视频 | 狂野欧美激情性xxxx| 热re99久久精品国产66热6| cao死你这个sao货| av免费在线观看网站| 亚洲国产欧美一区二区综合| 国产精品免费视频内射| 桃红色精品国产亚洲av| 老汉色∧v一级毛片| 国产精品成人在线| 每晚都被弄得嗷嗷叫到高潮| 国产成人av教育| 日韩制服丝袜自拍偷拍| 国产成人免费观看mmmm| 国产一区有黄有色的免费视频| 久久久久视频综合| 精品视频人人做人人爽| 国产精品 欧美亚洲| 久热这里只有精品99| 国产男女内射视频| 热99久久久久精品小说推荐| 两个人看的免费小视频| 亚洲精品美女久久av网站| 亚洲欧美日韩高清在线视频 | 超碰成人久久| 老鸭窝网址在线观看| 九色亚洲精品在线播放| 91国产中文字幕| 亚洲精品国产区一区二| 99热国产这里只有精品6| 自线自在国产av| 久久这里只有精品19| 97在线人人人人妻| 欧美成人免费av一区二区三区 | 国产一区二区三区综合在线观看| 久久国产亚洲av麻豆专区| 91成年电影在线观看| 在线观看舔阴道视频| 国产精品av久久久久免费| 无限看片的www在线观看| 男女之事视频高清在线观看| 欧美精品亚洲一区二区| 老熟女久久久| 菩萨蛮人人尽说江南好唐韦庄| 97在线人人人人妻| 午夜激情久久久久久久| 国产免费av片在线观看野外av| 伦理电影免费视频| 老汉色av国产亚洲站长工具| 亚洲精品久久午夜乱码| 国产不卡一卡二| 女人精品久久久久毛片| 亚洲一卡2卡3卡4卡5卡精品中文| 精品少妇久久久久久888优播| 狠狠精品人妻久久久久久综合| 国产福利在线免费观看视频| 国精品久久久久久国模美| 精品人妻在线不人妻| av福利片在线| 亚洲欧洲日产国产| 在线观看舔阴道视频| 18禁国产床啪视频网站| 国产97色在线日韩免费| 亚洲熟女毛片儿| 99国产精品一区二区蜜桃av | www.熟女人妻精品国产| 天天躁狠狠躁夜夜躁狠狠躁| 国产极品粉嫩免费观看在线| 精品国产亚洲在线| 99精国产麻豆久久婷婷| 最新美女视频免费是黄的| 午夜免费成人在线视频| 亚洲黑人精品在线| 99久久99久久久精品蜜桃| 一二三四社区在线视频社区8| 精品国内亚洲2022精品成人 | av网站免费在线观看视频| 亚洲五月色婷婷综合| 久久午夜亚洲精品久久| 嫩草影视91久久| 国产精品久久久久久精品电影小说| 满18在线观看网站| 成在线人永久免费视频| 国产男女超爽视频在线观看| 99精品欧美一区二区三区四区| 久久国产精品男人的天堂亚洲| 欧美精品高潮呻吟av久久| 国产精品香港三级国产av潘金莲| 两个人免费观看高清视频| 99国产精品免费福利视频| 国产精品自产拍在线观看55亚洲 | avwww免费| 久久av网站| 成人免费观看视频高清| 俄罗斯特黄特色一大片| 欧美精品人与动牲交sv欧美| 亚洲色图 男人天堂 中文字幕| 国产精品欧美亚洲77777| 最近最新免费中文字幕在线| 一级毛片女人18水好多| 日韩免费高清中文字幕av| av免费在线观看网站| 午夜精品国产一区二区电影| 国产在线免费精品| 国产成人欧美在线观看 | 中文字幕高清在线视频| 少妇被粗大的猛进出69影院| 亚洲色图 男人天堂 中文字幕| 9191精品国产免费久久| 成年动漫av网址| 中文欧美无线码| 亚洲成人手机| 国产又色又爽无遮挡免费看| 汤姆久久久久久久影院中文字幕| 中文字幕高清在线视频| 男女无遮挡免费网站观看| 在线观看免费日韩欧美大片| 色播在线永久视频| 亚洲精品久久成人aⅴ小说| 久久午夜亚洲精品久久| 精品久久久精品久久久| av视频免费观看在线观看| 99香蕉大伊视频| 久久精品亚洲熟妇少妇任你| 久久中文看片网| 99热网站在线观看| 国产精品99久久99久久久不卡| 99精品欧美一区二区三区四区| av片东京热男人的天堂| 久久国产精品影院| 成人亚洲精品一区在线观看| 自拍欧美九色日韩亚洲蝌蚪91| 国产亚洲一区二区精品| 俄罗斯特黄特色一大片| 制服人妻中文乱码| 人人妻,人人澡人人爽秒播| 又大又爽又粗| 午夜91福利影院| 亚洲,欧美精品.| 十分钟在线观看高清视频www| 亚洲成人免费电影在线观看| 久久国产精品大桥未久av| 丰满人妻熟妇乱又伦精品不卡| 18禁观看日本| 亚洲av国产av综合av卡| 亚洲午夜理论影院| 日韩欧美三级三区| 欧美一级毛片孕妇| 蜜桃国产av成人99| 男女之事视频高清在线观看| 精品国产乱子伦一区二区三区| 欧美在线黄色| 国产精品美女特级片免费视频播放器 | 国产成人系列免费观看| 欧美成狂野欧美在线观看| 老司机深夜福利视频在线观看| 十八禁网站网址无遮挡| 大码成人一级视频| 每晚都被弄得嗷嗷叫到高潮| 最近最新中文字幕大全免费视频| 国产精品电影一区二区三区 | 国产成人系列免费观看| 免费观看a级毛片全部| 激情在线观看视频在线高清 | 欧美黑人欧美精品刺激| 色综合欧美亚洲国产小说| 每晚都被弄得嗷嗷叫到高潮| 一级片免费观看大全| 在线观看舔阴道视频| 美女高潮喷水抽搐中文字幕| 老司机午夜福利在线观看视频 | 宅男免费午夜| 亚洲第一欧美日韩一区二区三区 | 亚洲成人国产一区在线观看| 少妇的丰满在线观看| 狠狠精品人妻久久久久久综合| 久久亚洲真实| 日韩免费高清中文字幕av| 亚洲精品粉嫩美女一区| 夫妻午夜视频| 涩涩av久久男人的天堂| 久久久国产成人免费| 又紧又爽又黄一区二区| 久久99一区二区三区| 精品高清国产在线一区| 国产精品免费一区二区三区在线 | 国产精品自产拍在线观看55亚洲 | 久久午夜综合久久蜜桃| 天天影视国产精品| 午夜老司机福利片| 妹子高潮喷水视频| 亚洲一区二区三区欧美精品| 我要看黄色一级片免费的| 亚洲中文av在线| 天堂8中文在线网| 国产高清激情床上av| 十分钟在线观看高清视频www| 999久久久国产精品视频| 欧美亚洲 丝袜 人妻 在线| 亚洲va日本ⅴa欧美va伊人久久| 国产成人精品在线电影| 亚洲 欧美一区二区三区| a级片在线免费高清观看视频| 欧美日韩亚洲国产一区二区在线观看 | 视频在线观看一区二区三区| av不卡在线播放| 日韩熟女老妇一区二区性免费视频| 久久国产精品人妻蜜桃| 欧美黑人精品巨大| 人妻久久中文字幕网| 免费看a级黄色片| 黄色片一级片一级黄色片| 欧美日韩黄片免| 超色免费av| 麻豆乱淫一区二区| cao死你这个sao货| 色婷婷久久久亚洲欧美| 肉色欧美久久久久久久蜜桃| 亚洲午夜理论影院| 90打野战视频偷拍视频| 免费在线观看日本一区| 高清视频免费观看一区二区| 欧美精品av麻豆av| 久热这里只有精品99| 成人三级做爰电影| 午夜福利视频在线观看免费| 菩萨蛮人人尽说江南好唐韦庄| 天天躁夜夜躁狠狠躁躁| 午夜精品久久久久久毛片777| 不卡一级毛片| 国产精品成人在线| 国产视频一区二区在线看| 中亚洲国语对白在线视频| 国产精品久久久久久精品电影小说| 满18在线观看网站| 欧美激情久久久久久爽电影 | 精品免费久久久久久久清纯 | 久久国产亚洲av麻豆专区| 国产欧美日韩精品亚洲av| 91老司机精品| 亚洲成av片中文字幕在线观看| 人人澡人人妻人| 亚洲av美国av| 丰满迷人的少妇在线观看| 精品乱码久久久久久99久播| 欧美大码av| 亚洲,欧美精品.| 91老司机精品| 在线天堂中文资源库| 久久青草综合色| 19禁男女啪啪无遮挡网站| 亚洲精品av麻豆狂野| 女人久久www免费人成看片| 啦啦啦在线免费观看视频4| 岛国毛片在线播放| 国产成人精品久久二区二区免费| 久久久国产精品麻豆| 王馨瑶露胸无遮挡在线观看| 国产男女超爽视频在线观看| 国产在视频线精品| 国产免费福利视频在线观看| 成年版毛片免费区|